Pricing, contracting, and commercial solutions globally for life sciences
Marbls partners with pharmaceutical and medical device and diagnostic manufacturers to provide practical, innovative services that address complex pricing, contracting and commercial excellence needs — driving the path of critical drugs, devices, and diagnostics to market.
A streamlined solution:
All in one Place.
The Marbls State Price
Transparency Reporting Solution
Our State Price Transparency solution provides a manufacturer everything they need from tracking legislation to submitting all necessary reporting to stay in compliance with the respective States. With advanced what-if analysis on prospective changes, the spark solution is used by the largest pharmaceutical companies as well as biotech and generic manufacturers.
Introducing our latest venture to serve the life sciences
MarblsLabs is our new division focused on developing innovative solutions to address unmet needs in the Life Sciences industry. It is where our leading-edge State Price Transparency product, spark, and our newest product for Fair Market Value had its origins.
Our team can develop bespoke products for our clients across the globe using various full stack platforms and technologies with practical integration of AI.
Why Marbls
Solving business and technology challenges with practical solutions and global presence
Who We Serve
Partnering with pharma, emerging biotech and MD&D manufacturers
Our dedicated teams serve life science companies across numerous sectors, from rare disease, mid-tier and large pharma to biotech, generics and medical device and diagnostics manufacturers.
Marbls’ Latest
Graded A for Sustainability
Marbls continues work on its obligations towards Sustainability consistently exceeding its marks with a Grade A score from our clients.
Marbls is committed to sustainability and
corporate responsibility
Marbls celebrates a commitment towards sustainability and a low-carbon economy. Within the life sciences industry, we are not only seeing some of our pharmaceutical clients set ambitious targets towards emissions reductions for themselves, but they expect their supply chain partners to commit to the same sustainability initiatives. Setting a standard sustainability requirement for suppliers creates a ripple effect and we hope to see this positive influence transcend throughout the life sciences industry. As a strong advocate for sustainability, Marbls is taking steps to commit to science-based targets. We urge all of our clients and partners to also make a commitment and set actionable targets towards sustainability.
Commitment to
Science-based Targets
Commitment to
Sustainability Initiatives
Create a
Ripple Effect
